TABLE 2.
Mean HbA1c (mmol/mol) | Sd | 95% CI | p | |
---|---|---|---|---|
All patients (N = 172) | ||||
HbA1c(4) | 56.9 | 12.2 | 55.1–58.7 | |
HbA1c(3) | 58.3 | 11.6 | 56.6–60.1 | |
Difference (HbA1c(4)‐(3)) | −1.4 | 8.2 | −2.6–−0.2 | 0.025 |
Stratified analyses | ||||
Pre‐lockdown HbA1c <52 mmol/mol (N = 60) | ||||
HbA1c(4) | 47.9 | 6.0 | 46.4–49.5 | |
HbA1c(3) | 47.1 | 4.4 | 46.0–48.2 | |
Difference (HbA1c(4)‐(3)) | 0.8 | 4.6 | −0.4–2.0 | 0.176 |
Pre‐lockdown HbA1c 52–59 mmol/mol (N = 44) | ||||
HbA1c(4) | 55.6 | 6.4 | 53.7–57.6 | |
HbA1c(3) | 55.7 | 2.0 | 55.1–56.3 | |
Difference (HbA1c(4)‐(3)) | −0.1 | 6.2 | −1.9–1.8 | 0.942 |
Pre‐lockdown HbA1c >59 mmol/mol (N = 68) | ||||
HbA1c(4) | 65.7 | 13.0 | 62.5–68.8 | |
HbA1c(3) | 69.9 | 8.3 | 67.9–71.9 | |
Difference (HbA1c(4)‐(3)) | −4.2 | 10.6 | −6.8–−1.7 | 0.002 |